Table 2.
Parameters | Median | Range |
---|---|---|
Pre-treatment | ||
SUVmax (g ml−1) | 12.1 | 3.7–22.0 |
MTV (cm3) | 21.5 | 1.0–122 |
TLG (g) | 92.9 | 2.7–924 |
ADCmean (×10−3 mm2 s−1) | 1.177 | 0.808–1.678 |
R2*mean (s−1) | 0.0600 | 0.0341–0.1175 |
Week 2 | ||
ADCmean (×10−3 mm2 s−1) | 1.553 | 1.112–2.100 |
R2*mean (s−1) | 0.0557 | 0.0283–0.089 |
Week 3 | ||
SUVmax (g ml−1) | 8.1 | 2.4–15.1 |
MTV (cm3) | 7.15 | 0.0–43.3 |
TLG (g) | 27.95 | 0.0–241.2 |
ADCmean (×10−3 mm2 s−1) | 1.724 | 1.037–2.510 |
R2*mean (s−1) | 0.0595 | 0.0393–0.1195 |
Week 5 | ||
ADCmean (×10−3 mm2 s−1) | 1.653 | 1.170–2.501 |
R2*mean (s−1) | 0.0632 | 0.0435–0.1158 |
Week 6 | ||
ADCmean (×10−3 mm2 s−1) | 1.738 | 0.919–2.190 |
R2*mean (s−1) | 0.0589 | 0.0401–0.1011 |
MTV, metabolic tumour volume; SUVmax, maximum standardized uptake value; TLG, total lesional glycolysis.